Peter Altman - Feb 13, 2024 Form 4 Insider Report for BioCardia, Inc. (BCDA;BCDAW)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Stock symbol
BCDA;BCDAW
Transactions as of
Feb 13, 2024
Transactions value $
$50,000
Form type
4
Date filed
2/15/2024, 07:00 AM
Previous filing
Aug 18, 2023
Next filing
Mar 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA;BCDAW Common Stock Purchase $50K +108K +24.17% $0.46 555K Feb 13, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA;BCDAW Warrant (right to buy Purchase +54.1K +80.1% 122K Feb 13, 2024 Common Stock 54.1K $0.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased.